INTRAVENOUS INFUSIONS LIMITED
INTRAVENOUS INFUSIONS LIMITED operates in various business sectors.
Market Cap & Net Worth: INTRAVENOUS INFUSIONS LIMITED (IIL)
INTRAVENOUS INFUSIONS LIMITED (GSE:IIL) has a market capitalization of $32.04 (GH₵473.10) as of March 18, 2026. Listed on the GSE stock exchange, this Ghana-based company holds position #50523 globally and #30 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INTRAVENOUS INFUSIONS LIMITED's stock price GH₵0.05 by its total outstanding shares 9462 (9.46K).
INTRAVENOUS INFUSIONS LIMITED Market Cap History: 2018 to 2026
INTRAVENOUS INFUSIONS LIMITED's market capitalization history from 2018 to 2026. Data shows change from $51.26 to $32.04 (-6.91% CAGR).
INTRAVENOUS INFUSIONS LIMITED Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INTRAVENOUS INFUSIONS LIMITED's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of IIL by Market Capitalization
Companies near INTRAVENOUS INFUSIONS LIMITED in the global market cap rankings as of March 18, 2026.
Key companies related to INTRAVENOUS INFUSIONS LIMITED by market ranking:
- Premiere Entertainment Inc (PSE:PHA): Ranked #50514 globally with a market cap of $33.52 USD ( ₱1.97K PHP).
- InterCare DX Inc (PINK:ICCO): Ranked #50515 globally with a market cap of $33.16 USD.
- Canna 8 Investment Trust (V:RCR-P): Ranked #50524 globally with a market cap of $32.51 USD ( CA$46.69 CAD).
- LIVINGTRUST MORTGAGE BANK PLC (XNSA:LIVINGTRUST): Ranked #50525 globally with a market cap of $32.46 USD ( ₦50.08K NGN).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #50514 | Premiere Entertainment Inc | PSE:PHA | $33.52 | ₱0.21 |
| #50515 | InterCare DX Inc | PINK:ICCO | $33.16 | $0.00 |
| #50524 | Canna 8 Investment Trust | V:RCR-P | $32.51 | CA$0.01 |
| #50525 | LIVINGTRUST MORTGAGE BANK PLC | XNSA:LIVINGTRUST | $32.46 | ₦5.24 |
INTRAVENOUS INFUSIONS LIMITED Historical Marketcap From 2018 to 2026
Between 2018 and today, INTRAVENOUS INFUSIONS LIMITED's market cap moved from $51.26 to $ 32.04, with a yearly change of -6.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GH₵32.04 | 0.00% |
| 2025 | GH₵32.04 | 0.00% |
| 2024 | GH₵32.04 | 0.00% |
| 2023 | GH₵32.04 | +25.00% |
| 2022 | GH₵25.63 | -20.00% |
| 2021 | GH₵32.04 | 0.00% |
| 2020 | GH₵32.04 | 0.00% |
| 2019 | GH₵32.04 | -37.50% |
| 2018 | GH₵51.26 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of INTRAVENOUS INFUSIONS LIMITED was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.04 USD |
| MoneyControl | $32.04 USD |
| MarketWatch | $32.04 USD |
| marketcap.company | $32.04 USD |
| Reuters | $32.04 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.